![Henrik Stenqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henrik Stenqvist
Director of Finance/CFO at
SWEDISH ORPHAN BIOVITRUM AB
Net worth: 6 M $ as of 2026-05-30
Profile
Presently, Henrik Stenqvist holds the position of Chief Financial Officer at Swedish Orphan Biovitrum AB and Co-Managing Director at Swedish Orphan Biovitrum GmbH (a subsidiary of Swedish Orphan Biovitrum AB). Mr. Stenqvist is also on the board of Midsona AB, Dova Pharmaceuticals, Inc., Swedish Orphan Biovitrum, Inc. and Swedish Orphan Biovitrum Ltd. Henrik Stenqvist previously held the position of Chief Financial Officer & Executive Vice President for Recipharm AB, Chief Financial Officer at Calliditas Therapeutics AB, Finance Director at Astra Export & Trading AB, Chief Financial Officer for MEDA Manufacturing GmbH and Chief Financial Officer, EVP-Finance & Procurement at Meda AB. Henrik Stenqvist received an MBA and an undergraduate degree from the University of Linköping.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-11 | 111,246 ( 0.03% ) | 5 M $ | 2026-05-30 | |
| 2025-12-30 | 2,971 ( 0% ) | 248 238 $ | 2026-05-30 |
Henrik Stenqvist active positions
| Companies | Position | Start |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Director of Finance/CFO | 2018-07-19 |
| DOVA PHARMACEUTICALS, INC. | Director/Board Member | 2019-11-11 |
| CTI BIOPHARMA CORP. | Treasurer | - |
| ORION OYJ | Director/Board Member | 2024-03-19 |
Swedish Orphan Biovitrum Ltd.
 Swedish Orphan Biovitrum Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs for rare diseases | Director/Board Member | 2018-07-19 |
Swedish Orphan Biovitrum GmbH
 Swedish Orphan Biovitrum GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching,developing and innovating therapies that improve the lives of people with rare diseases | Chief Executive Officer | - |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Director/Board Member | - |
Former positions of Henrik Stenqvist
| Companies | Position | End |
|---|---|---|
| MIDSONA AB | Director/Board Member | 2024-05-06 |
| RECIPHARM AB (PUBL) | Director of Finance/CFO | 2017-12-31 |
| ░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Training of Henrik Stenqvist
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Orion Oyj
 Orion Oyj Pharmaceuticals: MajorHealth Technology Manufactures and markets human and veterinary pharmaceuticals | Health Technology |
Meda AB
 Meda AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Recipharm AB
 Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
MEDA Manufacturing GmbH
 MEDA Manufacturing GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
MedCap AB
 MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements | Health Technology |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Midsona AB
 Midsona AB Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets nutritional supplements | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Astra Export & Trading AB | |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Swedish Orphan Biovitrum GmbH
Swedish Orphan Biovitrum GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching,developing and innovating therapies that improve the lives of people with rare diseases | Commercial Services |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Swedish Orphan Biovitrum Ltd.
Swedish Orphan Biovitrum Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs for rare diseases | Health Technology |
- Stock Market
- Insiders
- Henrik Stenqvist
